Environmental Issues of Disposable E-cigarettes Discussed in EU Parliament

Jan.10.2023
Environmental Issues of Disposable E-cigarettes Discussed in EU Parliament
A French MP addresses the European Parliament on the environmental impact of disposable e-cigarettes.

On January 4th, 2023, a French parliamentarian raised a concern at the European Parliament, highlighting the serious environmental problems caused by the popularity of disposable products. The question in full translation is as follows:


In recent years, a new type of disposable e-cigarette has been introduced to the market throughout Europe. This disposable product, which first appeared on the French market in 2020, has become a serious source of pollution and an environmental disaster.


These single-use electronic cigarettes contain metal components, lithium batteries, and integrated circuits. Various metals, including metal oxides, cobalt, and copper, can be found in these circuits. All of these substances must be carefully recycled as they are highly polluting. Unfortunately, in most cases, these e-cigarettes are not disposed of in a manner that allows for proper recycling.


Furthermore, according to a survey conducted by Alliance contre le tabac (a French anti-tobacco organization), 13% of young people between the ages of 13 and 16 have already tried electronic cigarettes. By targeting young people who prefer sweet flavors, tobacco companies are directing their marketing efforts towards underage youth.


Does the committee have knowledge of this situation, and if so, what plans do they have to address the issue and its harmful impact on the environment?


Does the committee intend to take measures to address the harm caused by these e-cigarettes to public health, especially the harm to the health of young people in Europe?


Full text screenshot of parliamentary issue | Source: European Parliament


In response to this matter, on the regular parliamentary meeting on January 6th, EU Commissioner for Environment Virginijus Sinkevičius answered the question on behalf of the EU. The full translated response is as follows:


The Disposable Electronic Cigarette (DEC) falls under the scope of the Waste Electrical and Electronic Equipment Directive and includes collection and recycling obligations. The directive emphasizes the broad producer responsibility, requiring DEC producers to support the collection and proper treatment of leftover DEC. Collection points for the disposal of electronic waste should be provided, and users can return used DEC at sales points.


Proposed regulations stipulate that from mid-2025, portable batteries in products including those made by DEC must be easily removable and replaceable by end-users. This will facilitate proper disposal and increase the collection of discarded batteries, thereby ensuring their recycling.


If DEC does not contain tobacco but rather nicotine-free e-liquid, it would not fall within the scope of the single-use plastics directive, as is typically the case. The directive is set to be reviewed in 2027, including a review of the list of affected products.


The committee acknowledges DEC's appeal to young people. The conclusions of the Health, Environment, and New Risks Science Committee in its opinion on e-cigarettes support this, as the committee reported moderate evidence indicating that e-cigarettes are a gateway to smoking for young people.


In this context, the European Commission is conducting a comprehensive assessment of the legislative framework for tobacco control to understand the EU's ability to respond to recent market developments and achieve its public health objectives. Any steps resulting from this assessment process will be guided by better regulation principles.


On January 5th, 2FIRSTS and IEVA held their annual strategic development conference for 2023, which included discussions on the environmental impact of disposable e-cigarettes. IEVA Chairman, Dustin Dahlmann, stated that a European recycling company dismantled three disposable e-cigarettes and found that 82% of their components were recyclable. 2FIRSTS COO, Guo Xiaoyu, announced that a leading domestic e-cigarette battery supplier has expressed interest in the project and has begun establishing recycling facilities in Europe. The company is also increasing R&D investment to advance the technology for dismantling e-cigarette batteries. The conference concluded with a collaboration agreement between 2FIRSTS and IEVA on disposable e-cigarette battery recycling efforts.


Ieva and 2FIRSTS hold online conference | Image source: 2FIRSTS


Zhao Tong, CEO of 2FIRSTS, believes that commercializing a disposable e-cigarette battery recycling program requires a "three-step" strategy. First, regulatory agencies need to establish policies that require e-cigarette manufacturers to recycle their waste products. Second, recycling technology needs to be improved, meaning the proportion of irrecoverable waste in discarded e-cigarettes is low or zero, something that Chinese manufacturers have already done well at, with their technology preparations already in place. Third, recycling must be a self-sustaining commercial activity rather than a public welfare project to ensure the sustainability of participating recycling enterprises.


The environmental issue surrounding disposable e-cigarettes has been officially brought to the forefront, and industry players as well as regulatory authorities can no longer ignore the problem. Additionally, questions from European Parliament members have raised concerns about disposable e-cigarette products enticing adolescents, and simplistic packaging may become a major trend in the development of disposable e-cigarettes in the future.


2FIRSTS will continue to follow this issue and provide the latest updates to readers both domestically and internationally. Stay tuned for further developments.


Further Reading:


Belgium may ban single-use e-cigarettes in six months.


Estonia may ban disposable e-cigarettes.


2FIRSTS and IEVA held their annual development strategy meeting where they agreed to enter into a deep collaboration moving forward.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
FDA’s Center for Tobacco Products detailed new PMTA review data and process changes at the 2026 FDLI conference. Pending PMTAs fell from about 450,000 at the start of 2025 to 135,000 by September 2026. CTP also discussed its 180-day review goal, current sPMTA pilot, alternate-supplier planning, more than 50,300 pending SE reports, and lessons from the nicotine pouch pilot already being applied to ENDS review.
Regulations
Oct.07
PMI's IQOS Extends ZAMNA Electronic-Music Partnership to Spain as Vogue España Publishes Branded Content
PMI's IQOS Extends ZAMNA Electronic-Music Partnership to Spain as Vogue España Publishes Branded Content
Philip Morris International's IQOS has extended its partnership with electronic-music event brand ZAMNA to Spain, setting up a House of IQOS at ZAMNA Madrid. Vogue España and Time Out Madrid subsequently published branded content clearly labeled as collaborations with IQOS. PMI has also expanded its company-owned IQOS boutique network in Spain to seven cities this year. The company says IQOS's adjusted heated-tobacco market share in Europe reached 12.6% in the first quarter of 2026, with Spain among its stronger-performing European markets.
Sep.20
Major U.S.  Vape Distributor Demand Vape Pays at Least $300,000 for White House Lobbying Amid Enforcement Pressure
Major U.S. Vape Distributor Demand Vape Pays at Least $300,000 for White House Lobbying Amid Enforcement Pressure
New York vape distributor Ecto World, which operates as Demand Vape, hired political consultant Roger Stone to lobby the Executive Office of the President on regulation of vaping and related products while facing state enforcement and multiple lawsuits. Public lobbying disclosures show that Ecto World paid at least $300,000 for the work through June 30, 2026. Separately, New York State announced in March that more than 28,500 pounds of vaping products tied to the company had been seized, while New York City and the state have pursued legal or enforcement actions. Public records do not show that the lobbying directly changed any specific regulatory or enforcement outcome.
Sep.08
STIIIZY Redesign Fails to Escape PAX Labs Patent Import Ban as Section 337 Case Also Involves China ALD
STIIIZY Redesign Fails to Escape PAX Labs Patent Import Ban as Section 337 Case Also Involves China ALD
U.S. Customs and Border Protection ruled that STIIIZY had not shown that the redesigned cannabis-vape products covered by its latest request fall outside an ITC limited exclusion order tied to PAX Labs patents. CBP accepted some of STIIIZY’s claim-construction and non-infringement arguments, but the company did not address two additional claims in the same patent. Earlier STIIIZY redesigned cartridges and certain associated components imported with them had received separate CBP clearance.
Sep.16
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
A commentary published in the international open-access, peer-reviewed Harm Reduction Journal argues that randomized controlled trials remain central to evaluating smoking cessation efficacy but cannot alone capture real-world uptake, complete switching, longer-term use and population impact of non-combustible nicotine products such as e-cigarettes, heated tobacco and nicotine pouches. The authors frame impact as “reach × efficacy” and call for real-world evidence to complement RCTs. Three days after publication, the FDA authorized three JUUL2 products and highlighted complete switching among adult smokers in explaining its decision, providing a timely regulatory backdrop to the debate.
Sep.08
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22